Werbung ausblenden

News zu Aelis Farma

Aelis Farma: Availability of the 2022 Half-year Financial Report · Uhr · Business Wire
Aelis Farma Will Participate in the Addiction 2022 Conference Dedicated to Innovation in the Treatment of Addictions · Uhr · Business Wire
Aelis Farma, a biopharmaceutical company developing a new generation of drugs for brain diseases, announces the success of its initial public offering and raises approximately €25 million on Euronext Paris · Uhr · Business Wire